Immunologic Deficiency Syndromes D007153

Diseases [C] » Immune System Diseases [C20] » Immunologic Deficiency Syndromes

Description

Syndromes in which there is a deficiency or defect in the mechanisms of immunity, either cellular or humoral.   MeSH

Subtype Terms (8)

Agammaglobulinemia
24 drugs (22 approved, 2 experimental)

Common Variable Immunodeficiency
32 drugs (26 approved, 6 experimental)

Deltaretrovirus Infections
 

Dysgammaglobulinemia
 

HIV Infections
1052 drugs (435 approved, 617 experimental)

Lymphopenia
5 drugs (2 approved, 3 experimental)

Phagocyte Bactericidal Dysfunction
 

Primary Immunodeficiency Diseases
68 drugs (30 approved, 38 experimental)



Organization Involved with Phase 4 Indications (82)

Organization Involved with Phase 3 Indications (87)

Organization Involved with Phase 2 Indications (54)

Hierarchy Tree View

UMLS Data


YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.